Medtech Matters

In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Jennifer Meade, president of the breast and skeletal health division at Hologic. She offers insight on the company’s recent acquisition activity as well as its partnership involving artificial intelligence. Meade also speaks to the importance of AI within Hologic technology and its efforts to encourage greater patient compliance. Specifically, the following questions are addressed.You were promoted to the position of president of the breast and skeletal health division in August of last year. What are your top priorities for your segment of Hologic in 2021 and beyond?Hologic didn’t waste time this year with an acquisition just a few days after the ball dropped on the new year. Can you speak to the reason behind the Somatex acquisition and where you see this fitting into your larger plan?It was announced last year that Hologic was working with RadNet on an artificial in